Heterozygous mutations in the gene encoding fibroblast growth factor 10 (FGF10) or its cognate receptor, FGF-receptor 2 IIIb (FGFR2-IIIb) result in two human syndromes -LADD (lacrimo-auriculo-dento-digital) and ALSG (Aplasia of lacrimal and salivary glands). To date, the partial loss-of-FGF10 function in these patients has been attributed solely to perturbed paracrine signalling functions between FGF10-producing mesenchymal cells and FGF10-responsive epithelial cells. However, the functioning of a LADD-causing G138E FGF10 mutation, which falls outside its receptor interaction interface, has remained enigmatic. In this study, we interrogated this mutation in the context of FGF10's protein sequence and threedimensional structure, and followed the subcellular fate of tagged proteins containing this or other combinatorial FGF10 mutations, in vitro. We report that FGF10 harbours two putative nuclear localization sequences, termed NLS1 and NLS2, which individually or co-operatively promote nuclear translocation of FGF10. Furthermore, FGF10 localizes to a subset of dense fibrillar components of the nucleolus. G138E falls within NLS1 and abrogates FGF10's nuclear translocation whilst attenuating its progression along the secretory pathway. Our findings suggest that in addition to its paracrine roles, FGF10 may normally play intracrine role/s within FGF10-producing cells. Thus, G138E may disrupt both paracrine and intracrine function/s of FGF10 through attenuated secretion and nuclear translocation, respectively. 
BIOCHEMICAL JOURNAL
Heterozygous mutations in the gene encoding fibroblast growth factor 10 (FGF10) or its cognate receptor, FGF-receptor 2 IIIb (FGFR2-IIIb) result in two human syndromes -LADD (lacrimo-auriculo-dento-digital) and ALSG (Aplasia of lacrimal and salivary glands). To date, the partial loss-of-FGF10 function in these patients has been attributed solely to perturbed paracrine signalling functions between FGF10-producing mesenchymal cells and FGF10-responsive epithelial cells. However, the functioning of a LADD-causing G138E FGF10 mutation, which falls outside its receptor interaction interface, has remained enigmatic. In this study, we interrogated this mutation in the context of FGF10's protein sequence and threedimensional structure, and followed the subcellular fate of tagged proteins containing this or other combinatorial FGF10 mutations, in vitro. We report that FGF10 harbours two putative nuclear localization sequences, termed NLS1 and NLS2, which individually or co-operatively promote nuclear translocation of FGF10. Furthermore, FGF10 localizes to a subset of dense fibrillar components of the nucleolus. G138E falls within NLS1 and abrogates FGF10's nuclear translocation whilst attenuating its progression along the secretory pathway. Our findings suggest that in addition to its paracrine roles, FGF10 may normally play intracrine role/s within FGF10-producing cells. Thus, G138E may disrupt both paracrine and intracrine function/s of FGF10 through attenuated secretion and nuclear translocation, respectively. However, the functioning of a LADD-causing G138E FGF10 mutation, which falls outside its receptor interaction interface, has remained enigmatic. In this study, we interrogated this mutation in the context of FGF10's protein sequence and threedimensional structure, and followed the subcellular fate of tagged proteins containing this or other combinatorial FGF10 mutations, in vitro. We report that FGF10 harbours two putative nuclear localization sequences, termed NLS1 and NLS2, which individually or co-operatively promote nuclear translocation of FGF10. Furthermore, FGF10 localizes to a subset of dense fibrillar components of the nucleolus. G138E falls within NLS1 and abrogates FGF10's nuclear translocation whilst attenuating its progression along the secretory pathway. Our findings suggest that in addition to its paracrine roles, FGF10 may normally play intracrine role/s within FGF10-producing cells. Thus, G138E may disrupt both paracrine and intracrine function/s of FGF10 through attenuated secretion and nuclear translocation, respectively. predicted to generate a truncated non-functional protein (Table 1) . However, the mechanism by which the third mutation -a Glycine (G) to Glutamic Acid (E) substitution at residue 138 -causes LADD [4] is unknown, and its apparent lack of involvement in receptor binding has raised the interesting possibility that FGF10 functions in multiple ways. Typically, FGF10 is secreted by mesenchymal cells to regulate epithelial cell growth and branching morphogenesis by activating the epithelially-expressed FGFR2-IIIb isoform [9] [10] [11] .
In addition to their paracrine signalling role, several FGFs are thought to function cell-autonomously, via intracellular partnership with scaffolding proteins [12] ;
receptor and non-receptor mediated re-uptake into cells [13] ; interaction with FGFRs within endosomes [14] ; and translocation into the nucleus/ nucleolus [15] . In some FGFs, this functional diversity is achieved via the generation and differential targeting of low versus high molecular weight (HMW) isoforms. For example, HMW FGF2 translocates to the nucleus to stimulate cell proliferation and negatively regulate bone mineralization [16, 17] . In contrast, nuclear FGF3 inhibits cell proliferation [18] .
Since the LADD-causing G138E mutation lies outside the FGF10-FGFR2 interaction interface, in this study we sought alternative explanation/s for its loss-of-function effects. Using bioinformatics, structural modelling, site-directed mutagenesis and intracellular trafficking analysis, we show that FGF10 harbours two putative nuclear localization sequences (NLS), with G138E falling within one of these. In contrast to the wild type, rat proteins bearing the equivalent mutation (G145E), or compound mutations in a second putative NLS site, fail to traffic into the nucleus and become hyper-glycosylated in the cytoplasm. Moreover, G145E fails to progress through the intracellular secretory pathway, and transient overexpression of wild type or FGF10 mutant proteins inhibit mesenchymal cell proliferation and differentiation in vitro. Our results suggest that nuclear trafficking promoted by two putative NLS motifs may be 7 an important aspect of FGF10 functionality. Hence, G138E mutation may work by reducing the bioavailability of FGF10 at two levels -as a secreted form to FGF10-responding cells, and as a nuclear form within FGF10-producing cells themselves.
Material and METHODS

Bioinformatics analysis
Primary protein sequences were obtained from UniProt database and sequence alignments were performed using ClustalW2. Protein 3D models were constructed in Chimera 1.9 using RCSB Protein Data Bank files (1nun). The search for NLS sequences was performed on rat and mouse FGF10 sequences using NLStradamus and NucPred software tools (Suppl. Fig. 1 ), freely available online.
Cloning and generation of mutant constructs
Using the appropriate restriction enzyme or HA tag encoding primers, a C-terminus HA-tagged FGF10 construct (FGF10-HA) was generated by PCR from a template plasmid encoding rat FGF10 cDNA (gift of Prof. Saverio Bellusci). These were scanned for undesirable mutations by Sanger sequencing before cloning as an EcoRI-NotI fragment into a mammalian expression vector, pN1, replacing an existing mCherry encoding fragment (Suppl. Fig. 2A ; Clonetech Laboratories Inc.). All point mutation-bearing FGF10 inserts (i.e. R/K to T substitutions) were generated by PCR using a QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies), and the relevant custom designed mutation-bearing primers (Suppl. Fig. 2B 
Subcellular Fractionation
Cell fractionation (cytoplasmic versus nuclear) was carried out following the protocol of Dimauro et al. [19] . In brief, 24 hours post transfection, 293T cells were washed in cold PBS, and pelleted. RT with 6M guanidine hydrochloride, and quantified using a spectrophotometer at 630nm. Each treatment was replicated 4 times.
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Detection of Fgf10 and FGF-Receptor isoforms by standard Rt-PCR
mRNA was isolated from HEK293T cells as well as differentiated undifferentiated ATDC5 cells using Trizol reagent, and subjected to Rt-PCR to detect Fgf10, the IIIb and IIIc isoforms of FGF-receptors 1-3 and FGFR4-IIIc, using previously described primers, protocols and cycle conditions [20, 21] .
Statistical analysis
Raw data was imported into and analysed by IBM SPSS Statistic 22 software.
Normally distributed data of equal variance were compared using Student's t Test (for two samples), or ANOVA post hoc Tukey (for greater than two samples).
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RESULTS
Putative Nuclear Localisation Sequences within FGF10
To investigate the mode/s of G145E function, we considered a potential intracellular mechanism involving nuclear trafficking. Active nuclear import of proteins requires nuclear localization sequence (NLS) motif/s, typically composed of a short stretch of positively charged amino acids such as arginine and lysine. NLS motifs can occur anywhere within a protein sequence, but must be exposed at the surface to allow for interaction with adaptor proteins such as importin-α and β-Kap, which facilitate protein trafficking through the nuclear pore complex [22] .
Using two independent software algorithms, NLStradamus [23] and NucPred [24] we identified a putative NLS motif encoded by amino acids 194 to 202 (RRGQKTRRK).
This is in addition to a more N-terminal NLS-like sequence (rat residues 142NKKGKLY148) noted by Kosman et al. [25] resembling, but not homologous to, a putative NLS found in FGF1 (i.e YKKPKLL). Here on we term these NLS2 and NLS1, respectively ( Fig. 1 ; Suppl. Fig. 1A ,B). Sequence alignments revealed that both NLS1 and NLS2 are fully conserved between rat, mouse and human, and show high conservation amongst other vertebrates (Fig. 1A) . Moreover, 3D-modelling showed that both motifs are exposed and reside away from the FGF10-FGFR2 interaction interface (Fig. 1B) . Strikingly, the LADD-type G138E falls within NLS1, and the G138 residue (rat G145) is not only conserved among different mammalian species (Fig.   1A ) but also across different FGF family members (Suppl. Fig. 1C,D) . To understand the significance of this high conservation, we scrutinized structural models of FGF10
and found that G145 interacts via a single H-bond with residue 196 (G196) of NLS2.
Furthermore, side chains of the basic residues within NLS2 extend away from the 14 protein surface (Fig. 1C ) allowing for potential contacts and interactions with other molecules, such as importins. Combined, these analyses suggested that NLS1 and NLS2 may function individually or co-operatively to promote nuclear import of endogenous FGF10.
Glycine 145 is critical for nuclear translocation of FGF10
To test the idea that FGF10 can translocate into the nucleus, we first analysed its cellular distribution. In the absence of commercial antibodies to specifically detect endogenously produced FGF10 by immunocytochemistry (our unpublished investigations), we followed the fate of FGF10 molecules tagged at their C-terminus with Haemagglutinin A (FGF10-HA). The relevant construct was generated by PCR from rat cDNA and cloned into pN1 mammalian expression vector (Addgene; Suppl. Fig. 2A,B) . This was not peculiar to ARPE cells, as similar extent of nuclear HA localization were found in transfected ATDC5 (chondrogenic mesenchymal) cells; primary adult mouse hypothalamic cells and HEK293T cells ( Fig. 2A,B ; data not shown). Moreover, a similar pattern and proportion of nuclear FGF10-HA was observed after transfection of serum-starved growth arrested cells, suggesting that its nuclear localization is not dependent on nuclear membrane breakdown during M phase ( Because LADD-causing G138E falls within a putative NLS (NLS1), next we asked whether introducing the mutant protein into cultured cells affects its nuclear localization. Thus, a corresponding C-terminus HA-tagged rat G145E construct was generated through site-directed mutagenesis (Suppl. Fig. 2 ), transfected into ARPE cells, and analysed as described for wild type FGF10-HA. Generation of G145E-encoding transcripts was also confirmed by real time Rt-PCR (data not shown).
Remarkably, in all cell types and at all time points examined, G145E-HA was excluded from the nucleus and restricted to the cytoplasm ( Fig. 2A,B) .
A glutamic acid substitution at residue 145 would create an acidic side chain, potentially disrupting the interaction of FGF10 with importins. On the other hand, a glycine residue per se could be critical for the nuclear translocation. To distinguish between these possibilities we also analysed the cellular distribution of HA-tagged G145V and G145A FGF10 constructs, choosing valine (V) or alanine (A) residue substitutions to mimic the small size of the glycine residue. However, both G145V-HA and G145A-HA molecules behaved like G145E-HA and showed nuclear exclusion (Suppl. Fig. 3A-D' ; data not shown).
These findings show that nuclear translocation of FGF10 can occur in multiple cell types -at least following its cytoplasmic introduction in our experimental settings.
Furthermore, a G138E LADD-type amino acid substitution can disrupt this trafficking and a glycine residue at position 138 (rat 145) is critical for this process.
Distinct NLS2 residues are also important for FGF10 nuclear trafficking 16 To determine the functionality and key elements of the NLS2 that may be important for nuclear translocation of FGF10, six basic residues (lysine and arginine) at positions 194, 195, 198, 200, 201 and 202 were individually mutated to a neutral threonine (T) using site directed mutagenesis ( Fig. 3A; Suppl. Fig. 2B ). In anticipation that mutagenesis of single NLS2 residues may not suffice -as observed in other NLS-bearing FGFs [26, 27] , we also generated three double-mutants (R194T/R195T, R200T/R201T and R200T/K202T) and a single quadruple-mutant construct (R194T/R195T/R200T/K202T, here on termed 4T-NLS2), all tagged with HA at their C-termini (Fig. 3A ). These were transfected into ARPE cells and subcellular distribution of HA was monitored by immunolabelling alongside sister cultures transfected with FGF10-HA or G145E-HA mutant.
We found that in contrast to G145E (NLS1), single residue substitutions in NLS2 had no significant impact on nuclear translocation of FGF10. However, double mutations significantly altered the balance of subcellular localization in favour of the cytoplasm, and the quadruple mutation (4T-NLS2) mimicked the effect of G145E, excluding FGF10 from the cell nucleus altogether (Fig. 3B-D) . This was verified by immunolabelling of transfected cells, or by immunoprobing their nuclear and cytoplasmic protein sub-fractions with antibodies against fibrillarin, a ribonucleolar protein, and GAPDH, a cytoplasmically-restricted protein, in combination with HA (Fig. 4) . First, FGF10-HA clearly co-localised with a subset of dense fibrillar components (DFC) found in the nucleolus (Fig. 4A) . Second, when compared to wild type FGF10, G145E and 4T-NLS appeared more abundant in the cytoplasmic fraction (Fig. 4B) . Interestingly, wild type FGF10 accumulates largely as its mature 21kDa form within the nucleus, whilst the cytoplasmic fraction additionally contains its 25kDa immature species (see below).
Since mutation of NLS2 mimics the effects of G145E mutation in NLS1, these findings suggest a distinct cluster of NL2 residues are also important for FGF10's nuclear trafficking, possibly acting independently or through a conformational association with NLS1.
Nuclear-excluded FGF10 mutants undergo hyperglycosylation and disrupt
FGF10's secretory pathway
To assess the molecular consequence of mutations that induce nuclear exclusion, whole cell lysates from ARPE cells transfected with wild type or mutant HA-tagged constructs were isolated, resolved by SDS page and probed with anti-HA antibodies.
The efficacy of anti-HA antibodies in these assays was verified using a control vector encoding HA-tagged SMAD2, detectable as a 55 kDa product (Fig. 5A ).
Wild type FGF10 is normally detected as a full-length 25kDa product as well as a mature 21kDa protein lacking the signal peptide, required for progression through the secretory pathway [28, 29] . Here, the 21kDa band was detected in all samples except for G145E and G145V (Fig. 5A) . In contrast, a novel strong 30kDa species was present in the G145E and G145V samples as well as R200T/K202T and 4T-NLS2, but not in R194/R195T, R194T, K198T single mutants or wild type. We also noted that the 25kDa product was generally stronger whenever the 30kDa protein was present (Fig. 5A ). Based on its size and the reduced conditions of SDS page, we posit that the 30kDa product is an unlikely product of intracellular ligand-ligand dimerization (>50 kDa) or ligand-FGFR partnership (>110 kDa). Since secreted FGFs can be glycosylated at multiple positions and FGF10 is predicted to carry at least 26 potential sites (Fig. 5B) , we investigated the possibility that the 30kDa species represents a hyperglycosylated form of FGF10. Cell lysates containing FGF10-HA, G145E-HA and a selection of single and double mutants as well as the 4T-NLS2 were subjected to 'N' deglycosylation with PNGase F, or to deglycosylation with a cocktail of 'O and N' degycosylating enzymes. As shown in Fig. 5C , Ndegylcosylation alone was sufficient to reduce not only the 30kDa, but also the 25KDa products in all samples, to a single 21kDa product. This suggests that 'O' glycosylation of FGF10 is cultured cells is minimal.
A likely interpretation of these findings is that whilst abolishing nuclear translocation, the LADD-type G145E traps the mutant protein in the cytoplasm, permitting its hyperglycosylation with a possible deleterious effect on its secretion. Unfortunately, low transfection levels did not permit isolation of sufficient secreted protein from the culture media in order to compare the secretory potential of wild type versus mutant FGF10, although poor FGF10 secretion from transfected cells has been noted by others [29] . Therefore, as an alternative approach we compared the cytoplasmic progression of wild type and G145E along the secretory pathway.
G145E mutant protein accumulates within the Endoplasmic Reticulum
To examine progression through the secretory pathway, we compared the distribution of FGF10-HA, G145E-HA and 4T-NLS2-HA in three subcellular compartments that define the successive stages of secretion. Thus, transfected cells were co-immunolabelled with anti-HA as well as antibodies against ERp60, an early secretory pathway chaperone within ER; βCOP, a marker of transport between ER and Golgi; and TGN46, demarcating Golgi and vehicle transport stages (Schematic, Fig. 6A ). Close scrutiny of high resolution images from randomly selected cells
showed that whilst FGF10-HA colocalised with all three markers (Fig. 6B,C,F,I ), expression of G145E-HA was restricted to the ERp60-positive compartment ( Fig.   19 6B,D,G,J), and 4T-NLS2 showed a much weaker phenotype (Fig. 6B ,E,H,K). In agreement with whole cell lysate analysis (Fig. 5A) , these results suggest that the G145E mutant protein fails to progress through the secretory pathway. However, the causal relationship between nuclear exclusion, hyperglycosylation and secretion cannot be wholly ascertained from our experimental approach.
Proliferation and differentiation of ATDC5 cells is differentially affected by misexpression or exogenous treatment with FGF10
An important function of FGF10 is to regulate the formation and patterning of cartilage in vivo [30, 31] . To test whether the perturbation of cellular trafficking Fig. 7D-J) . Separately, we also measured the rate of differentiation of 20 non-transfected ATDC5 cells in response to exogenously applied FGF10 (R&D systems; concentration ranges 1, 10 or 100 ng/ml). No discernable effect on cell differentiation was noted at 1 or 100 ng/ml, but a higher level of cell death was evident at 100ng/ml. However, and in contrast to FGF10 transfections, 10ng/ml of exogenous FGF10 promoted ATDC5 cell differentiation, and, supplementation of FGF10-HA transfected cultures with exogenous FGF10 partially rescued the inhibitory effects of FGF10-HA (Fig. 7I,I ' and J; data not shown).
In sum, although abrogation of nuclear trafficking does not yield a unique effect, (Table 1) . However, the functioning of a FGF10 G138E residue substitution has remained enigmatic. In this study, we analysed this mutation in silico and modelled the equivalent rat protein (G145E) in vitro. Although we cannot exclude the possibility that G138E encodes an unstable protein targeted for rapid degradation in vivo, our results rather suggest that falling within a putative NLS sequence, G145E
works by attenuating the process of FGF10 secretion, coupled to a novel nuclear trafficking role. The latter is supported by the identification of a second putative NLS sequence within FGF10, the mutation of which also abrogates FGF10 nuclear localization. We propose therefore that the G138E pathology may involve two cellular compartments and multiple biological processes ie. attenuation of paracrine signalling in epithelial cells secondary to reduced FGF10 secretion by mesenchymal cells, as well as perturbed cell-autonomous FGF10 function/s in mesenchymal cells themselves (summarised schematically in Suppl. Figure 7 ).
Nuclear translocation of FGF10 and its putative functions
As a 21-25 kDa protein, FGF10 is in principle small enough to passively traffic in and out of the nuclear pore complex and attain an equal nuclear/ cytoplasmic cell distribution at any given time. However, we found that most transiently transfected cells exhibit predominantly cytoplasmic or nuclear FGF10 as late as 72 hours post 22 transfection, suggesting that FGF10 is actively compartmentalized and/or retained within the cell nucleus. This phenomenon is not a peculiarity of our transfection system since Kosman et al [25] showed that exogenously applied FGF10 can enter the cell nucleus, possibly in association with FGFRs. They also reported that mutagenesis of basic residues flanking G145 in NLS1 can diminish, but not abrogate, this route of nuclear localization. By contrast, we showed that the mutation of the evolutionary conserved glycine 145 alone abrogates both FGF10's nuclear localization and progression along the secretory pathway. It may be that the basic residues of NLS1 have a dual function of binding FGFRs and promoting nuclear entry. Interestingly, an arginine 187 to valine substitution in mouse NLS2 (Rat R194V) alters FGF10's extracellular receptor binding dynamics and converts it to an FGF7-like molecule in branching morphogenesis assays [32] . In our assays, mutation of R194 alone (to threonine) did not affect the normal rate of FGF10 nuclear trafficking, perturbing this function only in combination with other mutations in NLS2.
Dynamics and mechanisms of nuclear translocation notwithstanding, the significance and role of nuclear-targeted FGF10 molecules remains unknown. We showed that FGF10 becomes localized to a subset of dense fibrillar components of the nucleolus, demarcated by the expression of Fibrillarin. The nucleolus is important for the generation and assembly ribosomal RNA as well as non-coding RNAs involved in pre-mRNA splicing and protein synthesis, and, formation of RNA-telomerase complexes [33] . Hence, it is tempting to speculate that by associating with the molecular machinery of the nucleolus, FGF10 participates in one or more of the above processes to regulate gene expression or cell cycle control, akin to roles ascribed to nucleolar FGF2 and FGF3. Nucleolar FGF2 directly regulates synthesis 23 of ribosomal RNA and stimulates Polymerase I transcription through binding to UBF transcription factor [34] . Nucleolar FGF3 is postulated to inhibition cell proliferation by binding to NoBP protein [35] .
Targeting of FGF10 to the nucleus could also play a critical stoichiometric role in regulating the normal level of paracrine FGF10 signalling. Numerous studies show that the level of FGFR signalling is exquisitely regulated and is critical for multiple biological outcomes during normal development as well as pathological conditions [10] . A key factor in this process is the quantity and bioavailability of FGF ligands.
For example, FGF10 is a driver of hyperactive FGFR2 mutations that cause Apert syndrome, and its genetic knockdown in a mouse model of Apert syndrome rescues much of the related defects [36] . Hence, the amount of secreted FGF10, available for paracrine signalling in epithelial cells, may normally be determined by titration against its nuclear-targeted forms in mesenchymal cells.
A potential cell autonomous role for FGF10 within FGF10-expressing cells themselves, whether nuclear or otherwise, gains credence from the discovery of tissues wherein FGF10 is unconventionally expressed in the epithelial cell compartment, or, from which FGF10's cognate receptor, FGFR2-IIIb is absent.
Notably, FGF10 is atypically expressed in the developing Otic epithelium [37] where it regulates cell specification, in contrast to its paracrine regulation of cell proliferation or differentiation. Interestingly, a significant number of LADD syndrome patients suffer from hearing defects [1] . In the adult brain (hypothalamus), expression of vivo [38] and we showed that FGF10 can translocate into the nucleus of these cells in vitro (Fig. 1A) . Thus, it would be interesting to investigate whether partial-loss-of date, the mode of action for a G138E mutation (rodent equivalent, G145E) has remained unknown. A rare FGFR3 mutation has also been described [2] . 
